We are glad to present you with an overview of the Russian regulations in the sphere of pharmaceuticals and life sciences for the 1st half of 2023.
There are several digital initiatives in the healthcare sector, such as pilot launch of online sale of Rx medicines and the extension of experiment with track-and-trace system for medical devices. We see that the regulators are willing to take step forward and extend the period of registration of medical devices under national rules, but in other sectors they are taking closer look on current requirements and may apply stricter approach (e.g., implement additional requirements for food additives). All in all, the pharma industry and its regulatory framework is relatively stable now.
We hope that the information provided herein will be useful for you.